|
National Drug Council re-affirms support for National Strategy
The Australian National Council on Drugs (ANCD)
acknowledges the release of the House of Representatives Standing
Committee on
Family & Community Affairs report — ‘Road to
Recovery’ — an Inquiry into Substance Abuse in Australian
Communities.
The ‘Road to Recovery’ is a comprehensive report covering
a broad range of drugs including alcohol, tobacco, cannabis, heroin
and pyschostimulants. It also addresses many complex issues including
alcohol taxation, occupational health & safety, road trauma,
family functioning, the role of schools, health services and law
enforcement.
The 128 recommendations in the Report are very broad and far reaching,
and whilst the ANCD endorses many of the findings, it also has
very serious concerns about others.
Over the coming months, the ANCD looks forward to consulting further
with the government about its response to the Report.
It is expected that where specific recommendations are being seriously
considered, the ANCD will be given the opportunity to provide advice
to the government on whether, and how, such strategies can be translated
into effective practice.
It is also important to note that the ANCD supports the Australian
National Drug Strategy continuing to be built upon the pillars
of supply, demand and harm reduction. These pillars include prevention
of the uptake of drug use, providing a wide range of treatments
for those using drugs, and reducing the levels of harm for drug
users and the broader community.
Whilst noting the recent and somewhat unhelpful semantic debate
about national drug policy, the ANCD has re-affirmed its support
for a national drug strategy that is committed to preventing and
minimising the harm caused by drugs to individuals, families and
the wider community.
The ANCD’s position is based on the following accepted description
of harm minimisation as agreed by the Australian, State and Territory
governments, NGOs and other key bodies in 1998 as part of the National
Drug Strategic Framework for Australia.
“Harm minimisation refers to policies and programs aimed
at reducing drug related harm. It aims to improve health, social
and economic
outcomes for both the community and the individual and encompasses
a wide range of approaches including abstinence orientated strategies.
Both licit and illicit drugs are the focus of Australia’s
harm minimisation strategy. Harm minimisation includes preventing
anticipated harm and reducing actual harm. Harm minimisation is
consistent with a comprehensive approach to drug related harm,
involving a balance between demand reduction, supply reduction
and harm reduction”.
The ANCD is the principal advisory body to Government on drug
and alcohol issues.
For further information, please contact:
Major Brian Watters (Chairman)
0400 780 509
Mr Gino Vumbaca (Executive Officer)
0408 244 552 or 02 6279 1650
Top of page
Home | About
ANCD | Current initiatives
| Publications | Media releases |
Meeting schedule | Asia-Pacific | NIDAC | Consultants register | Funding opportunities |
Drugs in Australia |
Links | Contact us
Whilst all care has been made to ensure only authorised
material appears on this site, the Australian National Council on
Drugs accepts no responsibility for inaccurate or false representations
appearing herein.
© Australian National Council on Drugs 2007
Web design by Starkis Design
|